{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:48:47Z","timestamp":1773236927888,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T00:00:00Z","timestamp":1383177600000},"content-version":"vor","delay-in-days":303,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2013]]},"DOI":"10.6061\/clinics\/2013(10)05","type":"journal-article","created":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T13:41:39Z","timestamp":1382535699000},"page":"1318-1324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Ocular surface evaluation in patients treated with a fixed combination of prostaglandin analogues with 0.5% timolol maleate topical monotherapy: a randomized clinical trial"],"prefix":"10.1016","volume":"68","author":[{"given":"Heloisa Helena","family":"Russ","sequence":"first","affiliation":[]},{"given":"Pedro Ant\u00f4nio","family":"Nogueira-Filho","sequence":"additional","affiliation":[]},{"given":"Jeison","family":"de Nadai Barros","sequence":"additional","affiliation":[]},{"given":"Nubia Vanessa Lima","family":"de Faria","sequence":"additional","affiliation":[]},{"given":"Fabiano","family":"Montiani-Ferreira","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 \u00c1lvaro Pereira","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"Paulo Augusto Arruda","family":"Mello","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"6","key":"10.6061\/clinics\/2013(10)05_bib1","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archopht.120.6.714","article-title":"The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma","volume":"120","author":"Gordon","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.6061\/clinics\/2013(10)05_bib2","series-title":"The Glaucomas","first-page":"1375","article-title":"Pharmacology","volume":"3","author":"Ritch","year":"1996"},{"issue":"3","key":"10.6061\/clinics\/2013(10)05_bib3","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0002-9394(02)01980-3","article-title":"Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost","volume":"135","author":"Stewart","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.6061\/clinics\/2013(10)05_bib4","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0002-9394(14)70870-0","article-title":"Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost","volume":"124","author":"Johnstone","year":"1997","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.6061\/clinics\/2013(10)05_bib5","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0002-9394(00)00402-5","article-title":"Increased eyelid pigmentation associated with use of latanoprost","volume":"129","author":"Kook","year":"2000","journal-title":"Am J Ophhtalmol"},{"issue":"2","key":"10.6061\/clinics\/2013(10)05_bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archopht.123.2.186","article-title":"Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial","volume":"123","author":"Arcieri","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.6061\/clinics\/2013(10)05_bib7","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0161-6420(92)31847-0","article-title":"Ocular surface alteration after long-term treatment with antiglaucomatous drug","volume":"99","author":"Herreras","year":"1992","journal-title":"Ophthalmology"},{"issue":"1","key":"10.6061\/clinics\/2013(10)05_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1023\/A:1006051725115","article-title":"Adverse effects of topical antiglaucomatous medications on the conjunctiva and the lacrymal","volume":"22","author":"Nuzzi","year":"1998","journal-title":"Int Ophthalmol"},{"issue":"11","key":"10.6061\/clinics\/2013(10)05_bib9","first-page":"1437","article-title":"Adverse effects of topical antiglaucoma medication","volume":"112","author":"Broadway","year":"1994","journal-title":"I- The conjunctival cell profile. Arch Ophthalmol"},{"issue":"1","key":"10.6061\/clinics\/2013(10)05_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1034\/j.1600-0420.2000.078001037.x","article-title":"Short-term effect of latanoprost and timolol eye drops on tear fluid and the ocular surface in patients with primary open-angle glaucoma and ocular hypertension","volume":"78","author":"Thygesen","year":"2000","journal-title":"Acta Ophthalmol Scand"},{"issue":"3","key":"10.6061\/clinics\/2013(10)05_bib11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0002-9394(14)76730-3","article-title":"Conjunctival impression cytology in patients with glaucoma using long-term topical medication","volume":"112","author":"Brandt","year":"1991","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.6061\/clinics\/2013(10)05_bib12","first-page":"679","article-title":"Effect of latanoprost and timolol on the histopathology of the rabbit conjunctiva","volume":"42","author":"Mietz","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.6061\/clinics\/2013(10)05_bib13","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1001\/archopht.1994.01090230060021","article-title":"Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery","volume":"112","author":"Broadway","year":"1994","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.6061\/clinics\/2013(10)05_bib14","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ajo.2010.05.003","article-title":"Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination","volume":"150","author":"Centofanti","year":"2010","journal-title":"American Journal of Ophthalmology"},{"issue":"5","key":"10.6061\/clinics\/2013(10)05_bib15","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1590\/S0004-27492007000600005","article-title":"Conjunctival changes induced by prostaglandin analogues and timolol maleate: a histomorphometric study","volume":"70","author":"Russ","year":"2007","journal-title":"Arq Bras Oftalmol"},{"issue":"1","key":"10.6061\/clinics\/2013(10)05_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1590\/S0004-27492008000100004","article-title":"Tear film and ocular surface alterations in chronic users of antiglaucoma medications","volume":"71","author":"Baffa","year":"2008","journal-title":"Arq Bras Oftalmol"},{"issue":"12","key":"10.6061\/clinics\/2013(10)05_bib17","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1167\/iovs.02-0462","volume":"44","author":"Mietz","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.6061\/clinics\/2013(10)05_bib18","first-page":"782","article-title":"Flow cytometric analysis of HLA-DR, IL-6 and IL-8 expression by conjunctival epithelial cells from patients with prolonged topical antiglaucoma treatments","volume":"26","author":"Bensoussan","year":"2003","journal-title":"J Fr Ophtalmol"},{"issue":"7","key":"10.6061\/clinics\/2013(10)05_bib19","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1167\/iovs.04-1331","article-title":"In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva \u2013derived epithelial cells","volume":"46","author":"Guenoun","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.6061\/clinics\/2013(10)05_bib20","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/112067210301300608","article-title":"Impression cytology of the conjunctival epithelium after antiglaucomatous treatment with latanoprost","volume":"13","author":"Moreno","year":"2003","journal-title":"Eur J Ophthalmol"},{"issue":"12","key":"10.6061\/clinics\/2013(10)05_bib21","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1289\/ehp.10363","article-title":"Ambient Levels of Air Pollution Induce Goblet-Cell Hyperplasia in Human Conjunctival Epithelium","volume":"115","author":"Novaes","year":"2007","journal-title":"Environ Health Perspect"},{"issue":"12","key":"10.6061\/clinics\/2013(10)05_bib22","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.ophtha.2004.06.023","article-title":"Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term","volume":"111","author":"Baudouin","year":"2004","journal-title":"Ophthalmology"},{"issue":"3","key":"10.6061\/clinics\/2013(10)05_bib23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000059624","article-title":"Ocular Surface Changes Induced by Topical Antiglaucoma Monotherapy","volume":"216","author":"Cvenkel","year":"2002","journal-title":"Ophthalmologica"},{"issue":"2","key":"10.6061\/clinics\/2013(10)05_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1442-9071.2000.00237.x","article-title":"Adverse effects of topical antiglaucoma drugs on the ocular surface","volume":"28","author":"Arici","year":"2000","journal-title":"Clin Experiment Ophthalmol"},{"issue":"4","key":"10.6061\/clinics\/2013(10)05_bib25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1076\/ceyr.27.4.253.16603","article-title":"In vitro effects of preserved or preservative-free antiglaucoma medications on human complement system","volume":"27","author":"Blondin","year":"2003","journal-title":"Curr Eye Res"},{"issue":"3","key":"10.6061\/clinics\/2013(10)05_bib26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1755-3768.2010.01907.x","article-title":"Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication","volume":"88","author":"Uusitalo","year":"2010","journal-title":"Acta Ophthalmol"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222029635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222029635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/clinics.org.br\/uploads\/artigos\/cln-68-10\/cln-68-10-1318.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:17:55Z","timestamp":1761722275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222029635"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_abstract&pid=S1807-59322013001001318&lng=en&nrm=iso","label":"SCIELO"},{"URL":"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3798551\/?report=classic","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013]]}},"alternative-id":["S1807593222029635"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2013(10)05","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular surface evaluation in patients treated with a fixed combination of prostaglandin analogues with 0.5% timolol maleate topical monotherapy: a randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2013(10)05","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}